UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis

International journal of infectious diseases, 2019-10, Vol.87, p.15-20

2019

Volltextzugriff (PDF)

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset

Scientific reports, 2015-10, Vol.5 (1), p.14775-14775, Article 14775

2015

Volltextzugriff (PDF)

Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan

Journal of virology, 2018-03, Vol.92 (5)

2018

Volltextzugriff (PDF)

Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin

PLoS computational biology, 2021-01, Vol.17 (1), p.e1008535

2021

Volltextzugriff (PDF)

Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies

Antiviral research, 2016-09, Vol.133, p.218-222

2016

Volltextzugriff (PDF)

Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry

Journal of virology, 2024-07, Vol.98 (7), p.e0071424

2024

Volltextzugriff (PDF)

Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems

Antiviral research, 2016-12, Vol.136 (C), p.9-18

2016

Volltextzugriff (PDF)

Lassa fever in pregnancy with a positive maternal and fetal outcome: A case report

International journal of infectious diseases, 2019-12, Vol.89, p.84-86

2019

Volltextzugriff (PDF)

Identification of a clinical compound losmapimod that blocks Lassa virus entry

Antiviral research, 2019-07, Vol.167, p.68-77

2019

Volltextzugriff (PDF)

25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation

mBio, 2016-12, Vol.7 (6)

2016

Volltextzugriff (PDF)

The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry

Journal of antimicrobial chemotherapy, 2014-08, Vol.69 (8), p.2123-2131

2014

Volltextzugriff (PDF)

Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library

Antiviral research, 2022-01, Vol.197, p.105230-105230, Article 105230

2022

Volltextzugriff (PDF)

Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays

Viruses, 2018-11, Vol.10 (11), p.655

2018

Volltextzugriff (PDF)

A potent Lassa virus antiviral targets an arenavirus virulence determinant

PLoS pathogens, 2018-12, Vol.14 (12), p.e1007439-e1007439

2018

Volltextzugriff (PDF)

Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1

PLoS pathogens, 2018-09, Vol.14 (9), p.e1007322

2018

Volltextzugriff (PDF)

New opportunities for field research on the pathogenesis and treatment of Lassa fever

Antiviral research, 2008-04, Vol.78 (1), p.103-115

2008

Volltextzugriff (PDF)

Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion

Journal of virology, 2019-03, Vol.93 (6)

2019

Volltextzugriff (PDF)

Inactivation Validation of Ebola, Marburg, and Lassa Viruses in AVL and Ethanol-Treated Viral Cultures

Viruses, 2024-09, Vol.16 (9), p.1354

2024

Volltextzugriff (PDF)

Proximity interactome analysis of Lassa polymerase reveals eRF3a/GSPT1 as a druggable target for host-directed antivirals

Proceedings of the National Academy of Sciences - PNAS, 2022-07, Vol.119 (30), p.e2201208119

2022

Volltextzugriff (PDF)

The PI3K/Akt Pathway Contributes to Arenavirus Budding

Journal of Virology, 2012-04, Vol.86 (8), p.4578-4585

2012

Volltextzugriff (PDF)

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor

Viruses, 2021-09, Vol.13 (9), p.1763

2021

Volltextzugriff (PDF)

Arenavirus reverse genetics: New approaches for the investigation of arenavirus biology and development of antiviral strategies

Virology (New York, N.Y.), 2011-03, Vol.411 (2), p.416-425

2011

Volltextzugriff (PDF)

The Role of Receptor Tyrosine Kinases in Lassa Virus Cell Entry

Viruses, 2020-08, Vol.12 (8), p.857

2020

Volltextzugriff (PDF)

Determining Ribavirin’s mechanism of action against Lassa virus infection

Scientific reports, 2017-09, Vol.7 (1), p.11693-12, Article 11693

2017

Volltextzugriff (PDF)

Antiviral Activity of a Small-Molecule Inhibitor of Arenavirus Glycoprotein Processing by the Cellular Site 1 Protease

Journal of Virology, 2011-01, Vol.85 (2), p.795-803

2011

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(107)
Buchkapitel
(1)

Sprache

Englisch
(99)
Russisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Life Sciences & Biomedicine
(86)
Humans
(75)
Animals
(69)
Lassa Virus - Drug Effects
(65)
Antiviral Agents - Pharmacology
(59)
Lassa Virus
(54)
Virology
(54)
Arenavirus
(33)
Lassa Fever
(30)
Vero Cells
(29)
Viruses
(28)
Antiviral Agents
(27)
Pharmacology & Pharmacy
(27)
Biological And Medical Sciences
(26)
Microbiology
(24)
Cell Line
(22)
Lassa Fever - Drug Therapy
(22)
Virus Internalization - Drug Effects
(22)
Lassa Virus - Physiology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset

Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan

Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin

Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies

Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry

Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems

Lassa fever in pregnancy with a positive maternal and fetal outcome: A case report

Identification of a clinical compound losmapimod that blocks Lassa virus entry

25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation

The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry

Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library

Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays

A potent Lassa virus antiviral targets an arenavirus virulence determinant

Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1

New opportunities for field research on the pathogenesis and treatment of Lassa fever

Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion

Inactivation Validation of Ebola, Marburg, and Lassa Viruses in AVL and Ethanol-Treated Viral Cultures

Proximity interactome analysis of Lassa polymerase reveals eRF3a/GSPT1 as a druggable target for host-directed antivirals

The PI3K/Akt Pathway Contributes to Arenavirus Budding

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor

Arenavirus reverse genetics: New approaches for the investigation of arenavirus biology and development of antiviral strategies

The Role of Receptor Tyrosine Kinases in Lassa Virus Cell Entry

Determining Ribavirin’s mechanism of action against Lassa virus infection

Antiviral Activity of a Small-Molecule Inhibitor of Arenavirus Glycoprotein Processing by the Cellular Site 1 Protease

Suchergebnisse filtern